Pharmaceutical composition for cardiovascular and cerebrovascular diseases as well as preparation method and application thereof

Abstract

The invention discloses a pharmaceutical composition for cardiovascular and cerebrovascular diseases as well as a preparation method and application thereof. The pharmaceutical composition is prepared from the following raw materials: Chinese magnoliavine, radix angelicae sinensis, radix codonopsis pilosulae, radix astragali, rhizoma gastrodiae, saffron crocus, radix salviae miltiorrhizae, rhodiola rosea, radix polygalae, radix ophiopogonis, gynostemma pentaphyllum, turtle shell, radix notoginseng and rhizoma Chuanxiong. The invention also provides the application of the pharmaceutical composition. The pharmaceutical composition is used for preparing dissolved granules taken by patients with the cardiovascular and cerebrovascular diseases. The invention also provides a preparation method of the dissolved granules. According to the pharmaceutical composition for the cardiovascular and cerebrovascular diseases and the preparation method and application thereof, the pharmaceutical composition has the characteristics of being reasonable in formula, small in dosage, remarkable in effect, free of toxic and side effects, capable of taking effect rapidly and the like, and the prepared dissolved granules can be used for treating or preventing various cardiovascular and cerebrovascular diseases or applied to emergency treatment on sudden cardio-cerebral conditions.

Description

technical field [0001] The present invention relates to a pharmaceutical composition and its preparation method and application, in particular to a pharmaceutical composition for cardiovascular and cerebrovascular diseases, its preparation method and application. Background technique [0002] With the development of economy and society and the change of people's lifestyle, the incidence of cardiovascular disease has increased year by year. Cardiovascular death accounts for the first cause of death among urban and rural residents, and more than half of the people who die from cardiovascular disease each year die. in myocardial infarction. According to relevant statistics, the mortality rate caused by myocardial infarction has increased significantly in recent years, and the mortality rate of sudden myocardial infarction is as high as 11.9%, which has become a major disease with the highest fatality rate except cancer. [0003] Epidemiological surveys in recent years have sho...

AI Technical Summary

Problems solved by technology

[0004] In recent years, the incidence of myocardial infarction is still increasing gradually. The cause of acute myocardial infarction is coronary artery atherosclerosis, which causes one or more vessels to narrow the lumen and cause insufficient blood supply to the myocardium. At this time, the collateral circulation is not fully established. On this basis, once the blood supply is sharply reduced or interrupted, it will cause severe and persistent myocardial ischemia and hypoxia for more than 20-30 minutes, and acute myocardial infarction will occur. However, many patients have no signs of attack before.

And there is no drug product with effective first aid and preventive health care functions on the market at present, and there is a lack of specific drugs for treatment and health care.